Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL123176 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL28835914 | 0.97 | HDAC8 (0.46) | — | |
| Hydrochloric Acid SCHEMBL6503211 | 0.97 | HDAC8 (0.46) | — | |
| SCHEMBL29502455 | 0.97 | — | — | |
| SCHEMBL300758 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL7950735 | 0.95 | — | — | |
| Methane SCHEMBL15323400 | 0.95 | — | — | |
| Iodide SCHEMBL21810784 | 0.95 | — | — | |
| SCHEMBL31292048 | 0.95 | — | — | |
| Hydrochloric Acid SCHEMBL467422 | 0.95 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 311 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4719510-A1 | CROSS-LINKED MATERIAL COMPRISING POLYSACCHARIDE MOIETIES INTERCONNECTED BY ESTER BONDS | Merz Aesthetics GmbH (DE) | 2026-04-08 | — | — | EP | claimed |
| EP-3927685-B1 | A PROCESS FOR THE SYNTHESIS ANTHRANILIC DIAMIDE COMPOUNDS AND INTERMEDIATES THEREOF | PI INDUSTRIES LTD (IN) | 2025-10-08 | — | — | EP | claimed |
| WO-2025096939-A1 | STEREOSELECTIVE CRYSTALLIZATIONS OF CHOLIC ACIDS | SANDHILL ONE, LLC (US) | 2025-05-08 | — | — | WO | claimed |
| WO-2025059082-A1 | 5-BETA STEREOSELECTIVE REDUCTIONS OF 3-KETOCHOL-4-ENOIC ACID AND DERIVATIVES THEREOF | SANDHILL ONE, LLC (US) | 2025-03-20 | — | — | WO | claimed |
| EP-3774786-B1 | METHOD FOR THE PREPARATION OF A 2,4,5-TRISUBSTITUTED 1,2,4-TRIAZOLONE | BAYER AG (DE) | 2024-12-25 | — | — | EP | claimed |
| WO-2024240864-A1 | CROSS-LINKED MATERIAL COMPRISING POLYSACCHARIDE MOIETIES INTERCONNECTED BY ESTER BONDS | MERZ AESTHETICS GMBH (DE) | 2024-11-28 | — | — | WO | claimed |
| EP-3862431-B1 | METHOD FOR PRODUCING HAIRPIN SINGLE-STRAND RNA MOLECULES | TORAY INDUSTRIES (JP) | 2024-06-26 | — | — | EP | claimed |
| US-20230339906-A1 | A PROCESS FOR THE SYNTHESIS OF ANTHRANILIC ACID/AMIDE COMPOUNDS AND INTERMEDIATES THEREOF | PI INDUSTRIES LTD. (IN) | 2023-10-26 | — | — | US | claimed |
| EP-4217339-A1 | A PROCESS FOR THE SYNTHESIS OF ANTHRANILIC ACID/AMIDE COMPOUNDS AND INTERMEDIATES THEREOF | PI Industries Ltd. (IN) | 2023-08-02 | — | — | EP | claimed |
| CN-115557895-A | Pyrazole derivative and preparation method and application thereof | 贵州大学 | 2023-01-03 | — | — | CN | claimed |
| CN-114315919-A | Method for preparing On-DNA1,2, 4-triazole compound by using DNA coding compound library technology | 上海药明康德新药开发有限公司 | 2022-04-12 | — | — | CN | claimed |
| WO-2022064454-A1 | A PROCESS FOR THE SYNTHESIS OF ANTHRANILIC ACID/AMIDE COMPOUNDS AND INTERMEDIATES THEREOF | PI INDUSTRIES LTD. (IN) | 2022-03-31 | — | — | WO | claimed |
| WO-2026099466-A1 | TARGETED PROTEIN DEGRADATION | MONTE ROSA THERAPEUTICS AG (CH) | 2026-05-15 | — | — | WO | disclosed |
| US-20260115199-A1 | TRICYCLIC COMPOUNDS FOR THE TREATMENT OF CANCER | HOFFMANN-LA ROCHE INC. (US) | 2026-04-30 | — | — | US | disclosed |
| US-12600730-B2 | Substituted cyclopenta[c]pyrroles as ABHD6 antagonists | ONO PHARMACEUTICAL CO., LTD. (JP) | 2026-04-14 | — | — | US | disclosed |
| EP-4719510-A1 | CROSS-LINKED MATERIAL COMPRISING POLYSACCHARIDE MOIETIES INTERCONNECTED BY ESTER BONDS | Merz Aesthetics GmbH (DE) | 2026-04-08 | — | — | EP | disclosed |
| US-20030004172-A1 | Fused pyrimidinone matrix metalloproteinase inhibitors | HARTER WILLIAM GLEN (US) | 2003-01-02 | — | — | US | disclosed |
| US-5478835-A | Acyl coenzyme A: acyltransferase inhibitors; treatment of hyperlipemia and arteriosclerosis | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1995-12-26 | — | — | US | disclosed |
| US-5340807-A | Tricyclic compounds and intermediates thereof | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1994-08-23 | — | — | US | disclosed |
| EP-0497201-A1 | Tricyclic compounds and intermediates thereof | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1992-08-05 | — | — | EP | disclosed |